Measles, Mumps, Rubella and Varicella (MMRV) combination Vaccine 2024-2026 and (2026-2027, 2027-2028)

on Vaccine belonging to the National Vaccination Programme in Finland. The contract period is two years 2024 - 2026. The procurement contains two contract period renewals (1+1) to extend the contract for the periods 2026 - 2027 and 2027 - 2028. Estimated quantity for the contract period including co

ntract period renewals is 216.000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economical